User account menu Search Menu Novartis Financial Data Expected Currency Impact Our expected currency impact, if currencies stay at mid-November levels in 2021 and 2022 can be found below. Download the presentation (PDF 0.3 MB) Novartis Navigate Topics Explore Companies Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience

User account menu Search Menu Investors Novartis Financial Data Novartis provides the following information on the Group's strong financial performance since its creation in 1996. Annual Results Novartis annual results conference, including media releases and year-to-date figures. Learn More Quarterly Results View recent and archived quarterly results. Learn More SEC Filings Use the SEC’s EDGAR system to search and review all US disclosure filings by Novartis. Learn More Fixed-Income Securities Learn about the fixed-income securities issued by Novartis. Learn More Product Sales View sales data of major Novartis products by business franchise. Learn More Expected Currency Impact Expected currency impact, if currencies stay at mid-November levels in 2021 and 2022. Learn More Novartis Navigate Topics Explore Companies Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience Your privacy is important for us. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies, select “Cookie settings” for managing the different cookies or select “Reject all” for using only strictly necessary cookies. You can change your cookie settings at any point of time by pressing the cookie settings link on the website. Cookie Settings Reject all Accept all